Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-12

Clinical Trial Update: Effect of Partially Hydrolyzed Formula With Synbiotics on Skin Barrier Function [NA]

View source ↗

Summary

This clinical trial is evaluating whether a partially hydrolyzed formula with synbiotics affects skin barrier function in individuals with atopic dermatitis. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Partially Hydrolyzed Formula With Synbiotics

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Atopic Dermatitis (AD) | NA | Status: RECRUITING